Literature DB >> 18437855

Evaluation of the GenoCard as a tool for transport and storage of samples for tuberculosis molecular drug susceptibility testing.

Paolo Miotto1, Federica Piana, Giovanni Battista Migliori, Daniela Maria Cirillo.   

Abstract

Early identification and monitoring of the spread of resistant M. tuberculosis strains is essential to control tuberculosis. The paper-based transport device GenoCard enables the safe shipment of inactivated biological material and strains to be used for molecular detection of drug resistance.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18437855

Source DB:  PubMed          Journal:  New Microbiol        ISSN： 1121-7138            Impact factor:   2.479


  4 in total

1.  Dried culture spots for Xpert MTB/RIF external quality assessment: results of a phase 1 pilot study in South Africa.

Authors:  L E Scott; N Gous; B E Cunningham; B D Kana; O Perovic; L Erasmus; G J Coetzee; H Koornhof; W Stevens
Journal:  J Clin Microbiol       Date:  2011-10-05       Impact factor: 5.948

Review 2.  Laboratory diagnosis of tuberculosis in resource-poor countries: challenges and opportunities.

Authors:  Linda M Parsons; Akos Somoskövi; Cristina Gutierrez; Evan Lee; C N Paramasivan; Alash'le Abimiku; Steven Spector; Giorgio Roscigno; John Nkengasong
Journal:  Clin Microbiol Rev       Date:  2011-04       Impact factor: 26.132

3.  Application of MIRU-VNTR on smear slides: a shortcut for detection of polyclonal infections in tuberculosis patients.

Authors:  Mansour Kargarpour Kamakoli; Sharareh Khanipour; Morteza Masoumi; Hasan Ghajavand; Ghazaleh Farmanfarmaei; Abolfazl Fateh; Seyed Davar Siadat; Farzam Vaziri
Journal:  Mol Biol Rep       Date:  2020-01-14       Impact factor: 2.316

4.  Performance of Four Transport and Storage Systems for Molecular Detection of Multidrug-Resistant Tuberculosis.

Authors:  Marie Sylvianne Rabodoarivelo; Bélen Imperiale; Rina Andrianiavomikotroka; Angela Brandao; Parveen Kumar; Sarman Singh; Lucilaine Ferrazoli; Nora Morcillo; Voahangy Rasolofo; Juan Carlos Palomino; Peter Vandamme; Anandi Martin
Journal:  PLoS One       Date:  2015-10-02       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.